Chevy Chase Trust Holdings LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 640,300 shares of the healthcare conglomerate's stock after selling 53,617 shares during the period. UnitedHealth Group makes up 0.6% of Chevy Chase Trust Holdings LLC's investment portfolio, making the stock its 24th largest holding. Chevy Chase Trust Holdings LLC owned 0.07% of UnitedHealth Group worth $199,754,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors also recently added to or reduced their stakes in the business. Tweedy Browne Co LLC bought a new stake in UnitedHealth Group during the second quarter valued at approximately $342,000. Easterly Investment Partners LLC bought a new stake in UnitedHealth Group during the second quarter valued at approximately $2,133,000. Stratos Wealth Partners LTD. increased its stake in shares of UnitedHealth Group by 77.3% in the second quarter. Stratos Wealth Partners LTD. now owns 26,871 shares of the healthcare conglomerate's stock worth $8,383,000 after purchasing an additional 11,717 shares in the last quarter. Stratos Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 50.5% in the second quarter. Stratos Wealth Advisors LLC now owns 4,687 shares of the healthcare conglomerate's stock worth $1,462,000 after purchasing an additional 1,573 shares in the last quarter. Finally, Sage Private Wealth Group LLC increased its stake in shares of UnitedHealth Group by 107.9% in the second quarter. Sage Private Wealth Group LLC now owns 1,651 shares of the healthcare conglomerate's stock worth $515,000 after purchasing an additional 857 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of analyst reports. Wells Fargo & Company increased their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 7th. Zacks Research upgraded shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a report on Monday, October 6th. Sanford C. Bernstein lifted their price target on UnitedHealth Group from $379.00 to $433.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 8th. Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Piper Sandler cut their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Seventeen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $384.09.
Get Our Latest Report on UNH
UnitedHealth Group Stock Down 1.5%
Shares of UnitedHealth Group stock opened at $355.73 on Friday. The firm's 50 day moving average price is $327.27 and its 200-day moving average price is $346.01. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a market cap of $322.17 billion, a P/E ratio of 15.41, a PEG ratio of 2.33 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the firm earned $6.80 EPS. The firm's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.